Related Links Educational Materials About Clinical Trials Clinical Trials Questions to Ask Your Doctor Drug Information from MedlinePlus

Alternate Title
Basic Trial Information
Trial Description
     Purpose
     Eligibility
     Treatment/Intervention
Trial Contact Information
Registry Information

Alternate Title

Research Study to Correlate DNA Sequence Copy Number Abnormalities With Outcome in Patients With Advanced Epithelial Ovarian Cancer

Basic Trial Information

Phase	Type	Status	Age	Sponsor	Protocol IDs
No phase specified	Biomarker/Laboratory analysis	Approved-not yet active	Any age	NCI	GOG-8004 NCT00053235

Trial Description

Purpose:

Analyzing tissue samples from patients in the laboratory may help doctors learn more about cancer.

The purpose of this study is to analyze tissue samples from patients with ovarian cancer in the laboratory.

Eligibility:

Eligibility criteria include the following:

• Any age
• Enrolled in clinical trial GOG-0136 and a GOG chemotherapy trial
• For more information about the eligibility criteria for this trial, refer to the Health Professional version.

Final eligibility for a clinical trial is determined by the health professionals conducting the trial.

Treatment/Intervention:

A sample of the patient's tumor removed during previous surgery will be tested. Several genetic tests will be completed using the tumor sample.

Important:

If you are interested in participating in a clinical trial, contact your doctor for a referral or call a trial contact person listed below. You may see the same contact person listed at more than one site, however, if you call the number listed you can ask to speak to the study coordinator or person involved with the specific trial you are interested in. If you have questions about cancer or clinical trials, call the Cancer Information Service at 1-800-4-CANCER (1-800-422-6237). General information about clinical trials, including risks, benefits, and costs, can be found on NCI's Web site.

Trial Contact Information

Trial Lead Organizations

Gynecologic Oncology Group

David Gershenson, MD, Protocol chair		Ph: 713-745-2565; 800-392-1611

Registry Information
Official Title		A Pilot Study To Correlate DNA Sequence Copy Number Abnormalities With Outcome In Patients With Advanced Epithelial Ovarian Cancer
Registered in ClinicalTrials.gov		NCT00053235
Date Submitted to PDQ		2002-11-20
Information Last Verified		2007-03-08

Back to Top